Acorda Therapeutics wins IPRs
Clients Acorda Therapeutics
Jones Day served as co-counsel in the successful defense of two of Acorda Therapeutics' Orange Book patents relating to Ampyra®, in IPRs requested by the Coalition for Affordable Drugs (ADROCA) LLC and Kyle Bass et al. After Acorda filed its Patent Owner's Preliminary Responses, the PTAB denied institution of the IPRs.
Coalition for Affordable Drugs (ADROCA) LLC v. Acorda Therapeutics, Inc., IPR2015-00720, -00817 (PTAB)